0001209191-15-034732.txt : 20150416 0001209191-15-034732.hdr.sgml : 20150416 20150416205925 ACCESSION NUMBER: 0001209191-15-034732 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150414 FILED AS OF DATE: 20150416 DATE AS OF CHANGE: 20150416 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: XBiotech Inc. CENTRAL INDEX KEY: 0001626878 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8201 E. RIVERSIDE DRIVE STREET 2: BUILDING 4, SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78744 BUSINESS PHONE: 512-386-2930 MAIL ADDRESS: STREET 1: 8201 E. RIVERSIDE DRIVE STREET 2: BUILDING 4, SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78744 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCKENZIE W THORPE CENTRAL INDEX KEY: 0001211462 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37347 FILM NUMBER: 15776403 MAIL ADDRESS: STREET 1: 735 BROAD ST STREET 2: STE 1105 CITY: CHATTANOOGA STATE: TN ZIP: 37402 3/A 1 doc3a.xml FORM 3/A SUBMISSION X0206 3/A 2015-04-14 2015-04-14 0 0001626878 XBiotech Inc. XBIT 0001211462 MCKENZIE W THORPE 8201 E RIVERSIDE DRIVE, BLDG. 4, STE 100 AUSTIN TX 78744 1 0 1 0 Common Stock 3375000 D Common Stock 610996 I By Corporation Common Stock 100000 I By Foundation Common Stock 100000 I By Wife Stock Option 3.75 2009-11-30 2019-11-29 Common Stock 185000 D Stock Option 3.75 2010-01-25 2020-01-24 Common Stock 77000 D Stock Option 3.75 2010-02-01 2020-01-31 Common Stock 46000 D Stock Option 3.75 2010-03-29 2020-03-28 Common Stock 327000 D Stock Option 3.75 2010-07-14 2020-07-13 Common Stock 320000 D Stock Option 3.75 2010-12-15 2020-12-14 Common Stock 45000 D Stock Option 10.00 2011-12-31 2021-12-30 Common Stock 250000 D Stock Option 15.00 2014-01-01 2023-12-31 Common Stock 90000 D Stock Option 10.00 2014-03-01 2016-03-01 Common Stock 500000 D Stock Option 15.00 2015-01-01 2024-12-31 Common Stock 15000 D The Reporting Person purchased an option from the CEO of the Issuer on March 1, 2014 which granted him an option to acquire 500,000 shares of the Issuer's common stock at an exercise price of $10.00 per share for a period of two years from the grant date. Exhibit 24 - Power of Attorney /s/ Seth Goettelman under Power of Attorney for W. Thorpe McKenzie 2015-04-16 EX-24 2 attachment1.htm EX-24 DOCUMENT
                                POWER OF ATTORNEY

        Know all by these presents, that the undersigned hereby constitutes and
appoints Laura Holm, Seth Goettelman or John Simard with full power of
substitution, as the undersigned's true and lawful attorney-in-fact to:

     (1)  execute for and on behalf of the undersigned, in the undersigned's
          capacity as an officer and/or director of XBiotech Inc. or any
          successor thereto (the "Company"), Forms 3, 4, and 5 in accordance
          with Section 16(a) of the Securities Exchange Act of 1934 and the
          rules thereunder (the "Exchange Act"), Form 144 in accordance with
          Rule 144 under the Securities Act of 1933 ("Rule 144") and any other
          forms or reports, including, but not limited to, a Form ID, that the
          undersigned may be required to file in connection with the
          undersigned's ownership, acquisition or disposition of securities of
          the Company;

     (2)  do and perform any and all acts for and on behalf of the undersigned
          which may be necessary or desirable to complete and execute any such
          Form 3, 4 or 5, Form 144 or other form or report, complete and execute
          any amendment or amendments thereto and timely file such form or
          report with the Securities and Exchange Commission and any stock
          exchange or similar authority; and

     (3)  take any other action of any type whatsoever in connection with the
          foregoing which, in the opinion of such attorney-in-fact, may be of
          benefit to, in the best interest of, or legally required by, the
          undersigned, it being understood that the documents executed by such
          attorney-in-fact on behalf of the undersigned pursuant to this Power
          of Attorney shall be in such form and shall contain such terms and
          conditions as such attorney-in-fact may approve in such
          attorney-in-fact's discretion.

        The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of attorney and the
rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Exchange Act or
Rule 144.

        This Power of Attorney revokes any previous Power of Attorney filed with
the Company for the purposes set forth herein and shall remain in full force and
effect until the undersigned is no longer required to file Forms 3, 4 and 5 with
respect to the undersigned's holdings of and transactions in securities issued
by the Company, unless expressly revoked before that time.

        IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 13th day of April, 2015.

                                        /s/ W. Thorpe Mckenzie
                                        ----------------------------------------
                                        W. Thorpe Mckenzie